Pesquisar
Ascendis Pharma A/S
ASNDAdicionar à lista de desejos
251.270USD
-1.730-0.68%
Fechamento 10-30 16:00（ET）
15.20BValor de mercado
36.19P/L TTM
Sobre o Ascendis Pharma A/S Empresa
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).
Ascendis Pharma A/S Perfil
Código da empresaASND
Nome da EmpresaAscendis Pharma A/S
Data de listagemJan 28, 2015
CEOMoller Mikkelsen (Jan)
Número de funcionários- -
Tipo de títulosDepository Receipt
Fim do ano fiscalJan 28
EndereçoTuborg Boulevard 12
CidadeHELLERUP
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísDenmark
Código postal2900
Telefone4570222244
Sitehttps://ascendispharma.dk/
Código da empresaASND
Data de listagemJan 28, 2015
CEOMoller Mikkelsen (Jan)
Executivos da empresa Ascendis Pharma A/S
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
11.39K
--
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
11.39K
--
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
2.43K
-9.72%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
2.43K
-9.72%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
2.16K
+49.63%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
2.16K
+49.63%
Dr. Aimee Shu, M.D.
Dr. Aimee Shu, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
1.92K
--
Dr. Aimee Shu, M.D.
Dr. Aimee Shu, M.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
1.92K
--
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
1.10K
+66.82%
Ms. Siham Imani
Ms. Siham Imani
Independent Director
Independent Director
1.10K
+66.82%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
11.39K
--
Mr. Flemming Steen Jensen
Mr. Flemming Steen Jensen
Executive Vice President, Product Supply and Quality
Executive Vice President, Product Supply and Quality
11.39K
--
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
2.43K
-9.72%
Mr. Lars Holtug, CPA
Mr. Lars Holtug, CPA
Independent Director
Independent Director
2.43K
-9.72%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
2.16K
+49.63%
Dr. Albert Cha, M.D., Ph.D.
Dr. Albert Cha, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
2.16K
+49.63%
Perguntas frequentes
Quem são os cinco principais acionistas de Ascendis Pharma A/S?
Os cinco principais acionistas de Ascendis Pharma A/S são: Mr. Flemming Steen Jensen
Quantas instituições possuem ações da Ascendis Pharma A/S (ASND)?
Em 2026Q1, 582 instituições possuíam ações da Ascendis Pharma A/S, com valor de mercado aproximado de 69.20M, representando 111.42% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -1676383.00.
Qual é a maior fonte de receita da Ascendis Pharma A/S?
Em 2026Q1, o segmento de negócios Commercial sale of products gerou a maior receita para Ascendis Pharma A/S, totalizando 314.91M e representando 92.82% da receita total.